Cost-effectiveness of the top 100 drugs by public spending in Canada, 2015–2021 : a repeated cross-sectional study / Étienne Gaudette, Shirin Rizzardo, Yvonne Zhang, Mina Tadrous, and Kevin R. Pothier...: H82-58/2024-PDF
"To assess the distribution and spending by cost-effectiveness category amongst those drugs with the highest public spending levels in Canada. The share of public pharmaceutical spending allocated to cost-effective and cost-ineffective drugs was estimated using Canadian Agency for Drugs and Technologies in Health (CADTH) cost-effectiveness assessments and Canadian public plan spending data from six provinces"--Introduction, page [1].
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.954009&sl=0
| Department/Agency |
|
|---|---|
| Title | Cost-effectiveness of the top 100 drugs by public spending in Canada, 2015–2021 : a repeated cross-sectional study / Étienne Gaudette, Shirin Rizzardo, Yvonne Zhang, Mina Tadrous, and Kevin R. Pothier = Rapport coût-efficacité des 100 médicaments représentant les plus grandes dépenses des régimes publics au Canada, 2015-2021 : une étude transversale répétée / Étienne Gaudette, Shirin Rizzardo, Yvonne Zhang, Mina Tadrous et Kevin R. Pothier. |
| Variant title |
|
| Publication type | Monograph |
| Language | Bilingual-[English | French] |
| Format | Digital text |
| Electronic document | |
| Parallel description | [French] |
| Note(s) |
|
| Publishing information |
|
| Author / Contributor |
|
| Description | 1 online resource (1 unnumbered page) : graphs |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: